Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Ventroni

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Internal Medicine|December 17, 2016
A young man with neck painGiuseppe Famularo, Guido Ventroni
The American Journal of the Medical Sciences|March 31, 2023
Transthyretin amyloid cardiomyopathyGiuseppe Famularo, Guido Ventroni
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2013
Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMPMassimiliano Pacilio, Guido Ventroni, Chiara Basile, et al.
Diagnostics (Basel, Switzerland)|March 3, 2018
Dosimetry-Based Consideration on Remission and Relapse after Therapy with <sup>223</sup>Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case ReportAnna Maria Mangano, Massimiliano Pacilio, Pasquale Ialongo, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Death from differentiated thyroid carcinoma: retrospective study of a 40-year investigationGiuseppe Ronga, Mauro Filesi, Teresa Montesano, et al.
Annals of Nuclear Medicine|November 29, 2015
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-upMassimiliano Pacilio, Guido Ventroni, Bartolomeo Cassano, et al.
BMC Nephrology|March 8, 2003
Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly populationGiorgio Coen, Santo Calabria, Silvia Lai, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|August 5, 2024
Liver transplantation for organ failure following multiple locoregional treatments for breast cancer metastasisGiammauro Berardi, Valerio Giannelli, Marco Colasanti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2015
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichlorideMassimiliano Pacilio, Guido Ventroni, Giuseppe De Vincentis, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 2, 2017
Gamma camera calibrations for the Italian multicentre study for lesion dosimetry in <sup>223</sup>Ra therapy of bone metastasesMassimiliano Pacilio, Bartolomeo Cassano, Rosanna Pellegrini, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Internal Medicine|December 17, 2016
A young man with neck painGiuseppe Famularo, Guido Ventroni
The American Journal of the Medical Sciences|March 31, 2023
Transthyretin amyloid cardiomyopathyGiuseppe Famularo, Guido Ventroni
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2013
Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMPMassimiliano Pacilio, Guido Ventroni, Chiara Basile, et al.
Diagnostics (Basel, Switzerland)|March 3, 2018
Dosimetry-Based Consideration on Remission and Relapse after Therapy with <sup>223</sup>Ra-Dichloride in Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases. A Case ReportAnna Maria Mangano, Massimiliano Pacilio, Pasquale Ialongo, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 10, 2002
Death from differentiated thyroid carcinoma: retrospective study of a 40-year investigationGiuseppe Ronga, Mauro Filesi, Teresa Montesano, et al.
Annals of Nuclear Medicine|November 29, 2015
A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-upMassimiliano Pacilio, Guido Ventroni, Bartolomeo Cassano, et al.
BMC Nephrology|March 8, 2003
Atherosclerotic ischemic renal disease. Diagnosis and prevalence in an hypertensive and/or uremic elderly populationGiorgio Coen, Santo Calabria, Silvia Lai, et al.
Annals of Hepato-Biliary-Pancreatic Surgery|August 5, 2024
Liver transplantation for organ failure following multiple locoregional treatments for breast cancer metastasisGiammauro Berardi, Valerio Giannelli, Marco Colasanti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2015
Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichlorideMassimiliano Pacilio, Guido Ventroni, Giuseppe De Vincentis, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 2, 2017
Gamma camera calibrations for the Italian multicentre study for lesion dosimetry in <sup>223</sup>Ra therapy of bone metastasesMassimiliano Pacilio, Bartolomeo Cassano, Rosanna Pellegrini, et al.
Pageof 2